Nov 11 (Reuters) - TherapeuticsMD Inc TXMD.O :
* THERAPEUTICSMD ANNOUNCES THIRD QUARTER 2021 FINANCIAL
RESULTS
* THERAPEUTICSMD INC - QTRLY TOTAL NET REVENUE $25.41
MILLION
VERSUS $19.34 MILLION
* THERAPEUTICSMD INC - QTRLY LOSS PER COMMON SHARE, BASIC
AND
DILUTED $0.11
* THERAPEUTICSMD INC - ANNOUNCED SIGNIFICANT COST SAVINGS
INITIATIVE DESIGNED TO REDUCE ANNUAL COSTS IN 2022 BY AT LEAST
$40 MILLION
Source text for Eikon: ID:nBw3gcfn9a
Further company coverage: TXMD.O
((Reuters.Briefs@thomsonreuters.com;;))